about
Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.Stem-cell gene therapy for the Wiskott-Aldrich syndrome.Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo.Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cellsSpecific elimination of CD133+ tumor cells with targeted oncolytic measles virus.Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.Colorectal cancer-initiating cells caught in the act.The inherent differentiation program of short-term hematopoietic repopulating cells changes during human ontogeny.Comprehensive genomic access to vector integration in clinical gene therapy.10-year stability of clinical-grade serum-free γ-retroviral vector-containing medium.High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.Targeted BiTE expression by an oncolytic vector augments therapeutic efficacy against solid tumors.Stable long-term blood formation by stem cells in murine steady-state hematopoiesis.The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells.Hematopoietic activity of human short-term repopulating cells in mobilized peripheral blood cell transplants is restricted to the first 5 months after transplantation.NRG1 Fusions in KRAS Wild-type Pancreatic Cancer.Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCsSalinomycin: Anti-tumor activity in a pre-clinical colorectal cancer modelSystematic Generation of Patient-Derived Tumor Models in Pancreatic CancerYou can count on this: barcoded hematopoietic stem cellsDistinct types of tumor-initiating cells form human colon cancer tumors and metastasesCell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal CarcinogenesisThe notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivoPheno-seq - linking visual features and gene expression in 3D cell culture systemsTranscriptome Profiling of Adipose Tissue Reveals Depot-Specific Metabolic Alterations Among Patients with Colorectal Cancer
P50
Q30525568-08A0AE70-801C-4AB8-90DA-BBCD0E285936Q33392766-46F8E6C3-5731-4C36-9DD7-247800B9A7C3Q33413888-D7EA5922-4C69-4F61-8971-E23BE74B403CQ33863533-03F7A938-603F-4B57-BC3A-307B4B03CA44Q34094502-223DC697-77A5-4488-BF57-53D8D5E29EADQ34508425-4FEF1D74-0826-45C7-94F5-EECB1E7A6DC0Q34545220-E752CAA0-4D6F-4378-820F-177EDCF17AFFQ34611732-0B49AF86-DC77-440F-AE97-526A8450FE09Q35939411-B659EAB2-9520-464F-8629-BC4B86368846Q35990723-C5B62E63-2DB4-49A0-93CF-37A9F1A9F7D9Q37305230-00D7FB60-9767-4F69-8225-65F1485BDE9FQ39215473-8C3B3071-6074-4A0A-9025-397B11CEC6BDQ40416521-A5079AEF-E4E3-4B2C-8ACB-D450C2334B29Q40980331-81D36A4D-F77F-4B38-8447-976419CC0890Q43269702-2E668FE1-30BF-464B-9ABA-4F72A407E2D7Q45855528-8BEEE497-A1C3-4D09-9C6D-E7D249496B6AQ45864829-A2330558-2D75-4B2E-847C-944CD3429E7CQ45873348-A15AF195-0342-48D4-8853-C3C9325665B9Q47142772-3AE8BA6F-9045-4AF2-AB1E-C70F50B6AC4AQ50043857-93CCFB7A-11DF-474E-924A-673E8E29C439Q50495284-33EF22AE-A9B5-46FC-B925-6CDDED5F8C97Q51041591-CF0A6DBB-047A-444F-A6BB-0349FAD50A86Q52894490-392D1DE8-C58B-4184-9746-499D91F81D53Q53330281-58D94EFD-E00E-4999-98CF-F2B9EBAA1049Q54978186-61D3379C-0480-4ABB-A66C-BDCF00AA613BQ56517488-53BBB1A0-4F4E-4B44-874D-CC2B76FB38E8Q64243717-F589E5F6-97D9-431C-8E66-AB9ED6173D95Q64245143-BD2E2D65-B629-4563-957D-90EA406E565BQ82360986-C5DCBEB8-BF6F-4AE1-9F27-8D9799E66750Q85062728-AF8F1EAE-0C95-4ED2-BDA7-6AFB899D618BQ89091552-63E6FA95-F180-4A59-859F-2B8D4E4712F3Q91651000-41113D8C-0A6A-4FA3-8137-16164656967BQ92882781-332D3760-694D-4650-8E7D-CEFFB3B60031Q92934780-4501EAD5-C11F-48C5-8EAD-299A52AF1913
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Claudia R Ball
@ast
Claudia R Ball
@en
Claudia R Ball
@es
Claudia R Ball
@nl
Claudia R Ball
@sl
type
label
Claudia R Ball
@ast
Claudia R Ball
@en
Claudia R Ball
@es
Claudia R Ball
@nl
Claudia R Ball
@sl
altLabel
Claudia Ball
@en
prefLabel
Claudia R Ball
@ast
Claudia R Ball
@en
Claudia R Ball
@es
Claudia R Ball
@nl
Claudia R Ball
@sl
P214
P106
P21
P214
P31
P496
0000-0002-1749-3791
P734
P735
P7859
viaf-11045380